Changes in glycaemic and other health parameters from baseline to end of follow-up
| Initiation HbA1c (%), (mmol/mol) | Final HbA1c (%), (mmol/mol) | Initial diabetic medications | Final diabetic medications | Initial weight (kg) | Final weight (kg) | Initial waist circumference (cm) | Final waist circumference (cm) | Number of days to come off insulin | |
| Patient 1 | 11, 96.7 | 7, 53 | insulin glargine 58. insulin aspart 22. canagliflozin 300 mg. metformin 1 g. | canagliflozin 300 mg | 83.8 | 73.8 | 100 | 87 | 5 |
| Patient 2 | 7.2, 55.2 | 6, 42.1 | insulin lispro mix 25–38/32 IU 25. | None | 61 | 50.4 | 89 | 70 | 18 |
| Patient 3 | 6.8, 50.8 | 6.2, 44.3 | metformin 1000 mg. insulin lispro mix 25–30/20 IU. | None | 97.1 | 88.1 | 123 | 110 | 13 |
HbA1C, haemoglobin A1C.